Cameron Gray is Director at Cue Biopharma, Inc. (CUE). They have made 1 open-market trade across 1 company since 2020, most recently 2022-06-14.
CIK 0001590583
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $152K since 2020, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CUE | 687,049 | $11.7M |
Shares reported on the most recent Form 4, priced at the 2022-06-16 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CUE | BUY | 2020-09-29 | 2020-10-01 | $15.15 | $152K | +4.9% | -26.8% | -16.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.